BIIB
Statement: Biogen Statement On Qui Tam Settlement
Monday, September 26, 2022 BiopharmaWatch Research 1 min read Key Takeaway: Statement: Biogen Statement On Qui Tam Settlement
Price reaction · baseline $197.78 (2022-09-23 close) · 1 other BIIB headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis
Full Press Release Details
Statement: Biogen Statement On Qui Tam Settlement.